Tumescent Technique for Regional Anesthesia Permits Lidocaine Doses of 35 mg/kg for Liposuction
Corresponding Author
JEFFREY A. KLEIN M.D.
Jeffrey A. Klein, M.D., is Assistant Clinical Professor, Dermatologic Plastic Surgery, Department of Dermatology, California College of Medicine, University of California, Irvine, California.
Address reprint requests to Jeffrey A. Klein, M.D., P.O. Box 1269, San Clemente, CA 92672.Search for more papers by this authorCorresponding Author
JEFFREY A. KLEIN M.D.
Jeffrey A. Klein, M.D., is Assistant Clinical Professor, Dermatologic Plastic Surgery, Department of Dermatology, California College of Medicine, University of California, Irvine, California.
Address reprint requests to Jeffrey A. Klein, M.D., P.O. Box 1269, San Clemente, CA 92672.Search for more papers by this authorThis paper was originally presented at the 1989 Annual Scientific Meeting of the American Academy of Cosmetic Surgery, January 15, 1989, Los Angeles, California.
Abstract
Abstract. The tumescent technique for local anesthesia permits regional local anesthesia of the skin and subcutaneous tissues by direct infiltration. The tumescent technique uses large volumes of a dilute anesthetic solution to produce swelling and firmness of targeted areas. This investigation examines the absorption pharmacokinetics of dilute solutions of lidocaine (0.1% or 0.05%) and epinephrine (1:1,000,000) in physiologic saline following infiltration into subcutaneous fat of liposuction surgery patients. Plasma lidocaine concentrations were measured repeatedly over more than 24 hours following the infiltration. Peak plasma lidocaine levels occurred 12–14 hours after beginning the infiltration. Clinical local anesthesia is apparent for up to 18 hours, obviating the need for postoperative analgesia. Dilution of lidocaine diminishes and delays the peak plasma lidocaine concentrations, thereby reducing potential toxicity. Liposuction reduces the total amount of lidocaine absorbed systemically, but does not dramatically reduce peak plasma lidocaine levels. A safe upper limit for lidocaine dosage using the tumescent technique is estimated to be 35 mg/kg. Infiltrating a large volume of dilute epinephrine assures diffusion throughout the entire targeted area while avoiding tachycardia and hypertension. The associated vasoconstriction is so complete that there is virtually no blood loss with liposuction. The tumescent technique can be used with general anesthesia or IV sedation. However, with appropriate instrumentation and surgical method, the tumescent technique permits liposuction of large volumes of fat totally by local anesthesia, without IV sedation or narcotic analgesia.
REFERENCES
- 1 Physicians' Desk Reference. Oradell , NJ , Medical Economics Company, Inc, 1989, p 640.
- 2 Personal communication. The Director of Clinical Research, Astra Pharmaceutical Products, Inc.
- 3 Personal communication. The US Food and Drug Administration. This information was obtained under the Freedom of Information Act.
- 4 Klein JA. Anesthesia for liposuction in dermatologic surgery. J Dermatol Surg Oncol 14: 1124–1132, 1988.
- 5 Cobb ME, Buckley N, Hu MW, et al. Homogeneous enzyme immunoassay for lidocaine in serum (abstract). Clin Chem 23: 1161, 1977.
- 6
Klein JA.
The tumescent technique for lipo-suction surgery.
Am J Cosmet Surg
4: 263–267, 1987.
10.1177/074880688700400403 Google Scholar
- 7 McKay W, Morris R, Mushlin P. Sodium bicarbonate attenuates pain on skin infiltration with lidocaine, with or without epinephrine. Anesth Analg 66: 572–574, 1987.
- 8 Stewart JH, Cole GW, Klein JA. Neutralized lidocaine with epinephrine for local anesthesia. J Dermatol Surg Oncol 15: 1081–1083, 1989.
- 9 Stewart JH, Chen SE, Cole GW, Klein JA. Neutralized lidocaine with epinephrine for local anesthesia, II. (In press.).
- 10 Klein JA. Infiltration regional anesthesia by the tumescent technique: Reduced blood loss and optimal fluid balance for liposuction. (In preparation.).
- 11 Apostol TM. Calculus, Vol I. Waltham , MA , Blaisdell Publishing Co, 1967, pp 2–5.
- 12 Raymond SA, Steffensen SC, Gugino LD, Strichartz GR. The role of length of nerve exposed to local anesthetics in impulse blocking action. Anesth Analg 68: 563–570, 1989.
- 13 Asken S. Liposuction Surgery and Autologous Fat Transplantation. East Norwalk , CT , Appleton & Lang, 1988, p 63.
- 14 Gumuncio CA, Bennie JB, Fernando B, et al. Plasma lidocaine levels during augmentation mammaplasty and suction-assisted lipectomy. Plast Reconstr Surg 84: 624–627, 1989.
- 15 Benowitz NL. Clinical applications of the pharmacokinetics of lidocaine. Cardiovasc Clin 6: 77–101, 1974.
- 16 Lillis PJ. Liposuction surgery under local anesthesia: Limited blood loss and minimal lidocaine absorption. J Dermatol Surg Oncol 14: 1145–1148, 1988.
- 17 Lewis CM, Hepper T. The use of high-dose lidocaine in wetting solutions for lipoplasty. Ann Plast Surg 22: 307–309, 1989.
- 18 Rowland M, Tozer TN. Clinical Pharmacokinetics: Concepts and Applications, 2nd Ed. Philadelphia , Lea & Febiger, 1989, Chap 19.
- 19 Boyes RN, Scott DB, Jebson PJ, et al. Pharmacokinetics of lidocaine in man. Clin Pharmacol Ther 12: 105–116, 1971.
- 20 Rowland M, Thomson PD, Guichard A, Melmon KL. Disposition kinetics of lidocaine in normal subjects. Ann N Y Acad Sci 179: 383–398, 1971.
- 21 de Jong RH. Local Anesthetics, 2nd Ed. Springfield , Ill , Charles C Thomas, 1977, pp 187–188.
- 22 Scott DB. Evaluation of clinical tolerance of local anaesthetic agents. Br J Anaesth 47: 328–333, 1975.
- 23 Campbell D, Adrinani J. Absorption of local anesthetics. JAMA 168: 873–877, 1958.
- 24 Hargrove RL, Hoyle JR, Parker JBR, et al. Blood lignocaine levels following intravenous regional analgesia. Anaesthesia 21: 37–41, 1966.
- 25 Schwartz M, et al. Antiarrhythmic effectiveness of intramuscular lidocaine: Influence of different injection sites. J Clin Pharmacol 14: 77–83, 1974.
- 26 Collinsworth KA, Kalman SM, Harrison DC. The clinical pharmacology of lidocaine as an antiarrhythmic drug. Circulation 50: 1217–1230, 1974.
- 27 Tucker GT, Moore DC, Bridenbaugh PO, et al. Systemic absorption of mepivacaine in commonly used regional block procedures. Anesthesiology 37: 277–287, 1972.
- 28 Raj PP, Rosenblatt R, Miller J, et al. Dynamics of localanesthetic compounds in regional anesthesia. Anesth Analg 56: 110–117, 1977.
- 29 Ecoffey C, Desparment A, Berdeaux A, et al. Pharmacokinetics of lignocaine in children following caudal anaesthesia. Br J Anaesth 56: 1399–1402, 1984.
- 30 Braid DP, Scott DB. Dosage of lignocaine in epidural block in relation to toxicity. Br J Anaesth 38: 596–602, 1966.
- 31 Braid DP, Scott DB. The systemic absorption of local analgesic drugs. Br J Anaesth 37: 394–404, 1965.
- 32 Inoue R, Suganuma T, Echizen H, et al. Plasma concentrations of lidocaine and its principal metabolites during intermittent epidural anesthesia. Anesthesiology 63: 304–310, 1985.
- 33 Blanco LJ, Reid PR, King TM. Plasma lidocaine levels following paracervical infiltration for aspiration abortion. Obstet Gynecol 60: 506–508, 1982.
- 34 Boyes RN, Scott DB, Jebson PJ, et al. Pharmacokinetics of lidocaine in man. Clin Pharmacol Ther 12: 105–116, 1971.
- 35 Stoelting RK. Plasma lidocaine concentrations following subcutaneous or submucosal epinephrine-lidocaine injection. Anesth Analg 57: 724–726, 1978.
- 36 Scott DB, Jebson PJR, Braid DP, et al. Factors affecting plasma levels of lignocaine and prilocaine. Br J Anaesth 44: 1040–1049, 1972.
- 37 Schwartz, ML, Covino BG, Narang RM, et al. Blood levels of lidocaine following subcutaneous administration prior to cardiac catheterization. Am Heart J 88: 721–723, 1974.
- 38 Kosowsky BD, Shahid IM, Gurinder SG, et al. Effect of local lidocaine anesthesia on ventricular escape intervals during permanent pacemaker implantation in patients with complete heart block. Am J Cardiology 51: 101–104, 1983.
- 39 Nattel S, Rinkenberger RL, Lehrman LL, Zipes DP. Therapeutic blood lidocaine concentrations after local anesthesia for cardiac electrophysiologic studies. N Engl J Med 301: 418–420, 1979.
- 40 Maloney JM, Lertora JJ, Yarborough J, Millikan LE. Plasma concentrations of lidocaine during hair transplantation. J Dermatol Surg Oncol 8: 950–954, 1982.
- 41 Nancarrow C, Rutten AJ, Runciman WB, et al. Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesth Analg 69: 276–283, 1989.
- 42 Rutten AJ, Nancarrow C, Mather LE, et al. Hemodynamic and central nervous system effects of intravenous bolus doses of lidocaine, bupivacaine, and ropivacaine in sheep. Anesth Analg 69: 291–299, 1989.
- 43 Tanz RD, Haskett T, Loehning RW, Fairfax CA. Comparative cardiotoxicity of bupivacaine and lidocaine in the isolated perfused mammalian heart. Anesth Analg 63: 549–556, 1984.
- 44 de Jong RH, Ronfeld RA, DeRosa RA. Cardiovascular effects of convulsant and supraconvulsant doses of amide local anesthetics. Anesth Analg 61: 3–9, 1982.
- 45 Cassuto J, Wallin G, Hogstrom S, et al. Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg 64: 971–974, 1985.
- 46 Bartlett EE, Hutaserani O. Xylocaine for relief of post-operative pain. Anesth Analg 40: 296–304, 1961.
- 47 Himes RS, DiFazio CA, Burney RG. Effects of lidocaine on the anesthetic requirements for nitrous oxide and halothane. Anesthesiology 47: 437–440, 1977.
- 48 Benowitz NL, Meister W. Clinical pharmacokinetics of lidocaine. Clin Pharmacokinet 3: 177–201, 1978.
- 49 Alper MH. Toxicity of local anesthetics. N Engl J Med 295: 1432–1433, 1976.
- 50 Finkelstein F. Massive lidocaine poisoning (letter). N Engl J Med 301: 50, 1979.
- 51 Covino BG. Systemic toxicity of local anesthetic agents (editorial). Anesth Analg 57: 387–388, 1978.
- 52 Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 51: 285–287, 1979.
- 53 Moore DC, Bridenbaugh LD, Thompson GB, et al. Factors determining dosage of amide-type local anesthetic drugs. Anesthesiology 47: 263–268, 1977.
- 54 Moore DC, Thompson GE, Crawford RD. Long-acting local anesthetic drugs and convulsions with hypoxia and acidosis. Anesthesiology 56: 230–232, 1982.
- 55 de Jong RH, Bonin JD. Local anesthetics: Injection route alters relative toxicity of bupivacaine. Anesth Analg 59: 925–928, 1980.
- 56 Gordh T. Xylocaine—a new local anesthetic. Anaesthesia 4: 4–9, 21, 1949.
- 57 Bashein G. Use of excessive lidocaine concentrations for local anesthesia (letter). N Engl J Med 302: 122, 1980.
- 58 Petterson LO, Akerman B. Influence of hyaluronidase upon local infiltration anaesthesia by lidocaine. Scand J Plast Reconstr Surg 18: 297–301, 1984.
- 59 Adriani J. The clinical pharmacology of local anesthetics. Clin Pharmacol Ther 1: 645–673, 1960.
- 60 Covino BG, Vassallo HG. Local Anesthetics: Mechanisms of Action and Clinical Use. New York , Grune & Stratton, 1976, pp 105–106.
- 61 Personal communication with Richard Hagert, M.D., Department of Plastic and Reconstructive Surgery, School of Medicine, University of South Carolina, Charleston, SC.
- 62 Piveral K. Systemic lidocaine absorption during liposuction. Plast Reconstr Surg 80: 643, 1987.
- 63 Swerdlow M, Jones R. The duration of action of bupivacaine, prilocaine and lignocaine. Br J Anaesth 42: 335–339, 1970.
- 64 Covino BG. Pharmacology of local anaesthetic agents. Br J Anaesth 58: 701–716, 1986.
- 65 Selden R, Sasahara AA. Central nervous system toxicity induced by lidocaine: Report of a case in a patient with liver disease. JAMA 202: 908–909, 1967.
- 66 Thomson PD, Melmon KL, Richardson JA, et al. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med 78: 499–508, 1973.
- 67 Thomson PD, Rowland M, Melmon KL. The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man. Am Heart J 82: 417–421, 1971.
- 68 Prescott LF, Adjepon-Yamoah KK, Talbot RG. Impaired lignocaine metabolism with patients with myocardial infarction and cardiac failure. Br Med J 1: 939–941, 1976.
- 69 Feely J, Wade D, McAllister CB, et al. Effect of hypotension on liver blood flow and lidocaine disposition. N Engl J Med 307: 866–869, 1982.
- 70 Knapp AB, et al. The cimetidine-lidocaine interaction. Ann Intern Med 98: 174–177, 1983.
- 71 Feely J, Wilkinson GR, McAllister CB, Wood AJJ. Increased toxicity and reduced clearance of lidocaine by cimetidine. Ann Intern Med 96: 592–594, 1982.
- 72
Tucker GT,
Bax NDS,
Al-Asady S, et al.
Effects of β-adrenoceptor antagonists on the pharmacokinetics of lignocaine.
Br J Pharmacol
17: 21S–28S, 1984.
10.1111/j.1365-2125.1984.tb02424.x Google Scholar
- 73 Ochs HR, Carstens G, Greenblatt DJ. Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. N Engl J Med 303: 373–376, 1980.
- 74 Branch RA, Shand DS, Wilkinson GR, Nies AS. The reduction of lidocaine clearance by d1 propranolol: An example of hemodynamic drug interaction. J Pharmacol Exp Ther 184: 515–519, 1973.
- 75 Conrad KA, Byers JM III, Finley PR, Burnham L. Lidocaine elimination: Effects of metoprolol and of propranolol. Clin Pharmacol Ther 33: 133–138, 1983.
- 76 Karlsson E, Collste R, Rowlins MD. Plasma levels of lidocaine during combined treatment with phenytoin and procainamide. Eur J Clin Pharmacol 7: 455–459, 1974.
- 77 de Jong RH. Toxic effects of local anesthetics. JAMA 239: 1166–1168, 1978.
- 78 de Jong RH, Heavner JE. Convulsions induced by local anesthetic: Time course of diazepam prophylaxis. Can Anaesth Soc J 21: 153–158, 1974.
- 79 Bernards CM, Carpenter RL, Rupp SM, et al. Effect of midazolam and diazepam premedication on central nervous system and cardiovascular toxicity of bupivacaine in pigs. Anesthesiology 70: 318–323, 1989.
- 80 Gregg RV, Turner PA, Denson DA, et al. ?1. Anesth Anal 67: 9–14, 1988.
- 81 Torbiner ML, Yagiela JA, Mito RS. Effect of midazolam pre-treatment on the intravenous toxicity of lidocaine with and without epinephrine in rats. Anesth Analg 68: 744–749, 1989.
- 82 Lillis P. Personal communication.